Drug delivery to the lung: Permeability and physicochemical characteristics of drugs as the basis for a pulmonary biopharmaceutical classification system (pBCS)

Journal of Epithelial Biology and Pharmacology

Volumn 3, Issue , 2010, Pages 1-14

  Eixarch, Helena ^a   Haltner Ukomadu, Eleonore ^a   Beisswenger, Christoph ^a   Bock, Udo ^a  

^a ACROSS BARRIERS GMBH   (Germany)

Author keywords

Absorption; BCS; Calu 3; In vitro in vivo correlation; pAEpC; pBCS; Permeability; Solubility

Indexed keywords

ATENOLOL; BETAMETHASONE; BUDESONIDE; CAFFEINE; CROMOGLYCATE DISODIUM; DEXAMETHASONE; DIGOXIN; FLUORESCEIN; FORMOTEROL; HYDROCORTISONE; IMIPRAMINE; LEFLUNOMIDE; LOSARTAN; MANNITOL; MENTHOL; METHOTREXATE; NICOTINE; OXYMETAZOLINE; RHODAMINE 123; SALAZOSULFAPYRIDINE; SALBUTAMOL; TALINOLOL; TERBUTALINE; TESTOSTERONE; TOPOTECAN; UNINDEXED DRUG; VINBLASTINE; ZALEPLON; ZOLPIDEM; ZOPICLONE;

ALGORITHM; ANIMAL CELL; ARTICLE; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG METABOLISM; DRUG PENETRATION; DRUG SAFETY; DRUG SOLUBILITY; DRUG TRANSPORT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG; NONHUMAN; PHYSICAL CHEMISTRY; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT DISEASE;

ANIMALIA;

EID: 77953459390     PISSN: None     EISSN: 18750443     Source Type: Journal    
DOI: 10.2174/1875044301003010001     Document Type: Article

References (33)

1. Leitner VM, Guggi D, Krauland AH, Bernkop-Schnurch A. Nasal delivery of human growth hormone: In vitro and in vivo evaluation of a thiomer/glutathione microparticulate delivery system. J Control Release 2004; 100: 87-95.
2. Arikan OK, Akarsu C, Unal B, Ergin A, Koc C. Effect of oxymetazoline nasal spray on intraocular pressure and retrobulbar hemodynamics. J Otolaryng 2006; 35: 30-5.
3. Gonda I. Systemic delivery of drugs to humans via inhalation. J Aerosol Med 2006; 19: 47-53.
4. Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995; 12: 413-20.
5. Guidance for industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage formas based on a biopharmaceutics classification system. FDA 2000; Available from: www.fda.gov/cder/guidance/index.htm.
6. Fagerholm U. Evaluation and suggested improvements of the biopharmaceutics classification system (BCS). J Pharm Pharmacol 2007; 59: 751-7.
7. Wu CY, Benet LZ. Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005; 22: 11-23.
8. Fagerholm U. The role of permeability in drug ADME/PK, interactions and toxicity--presentation of a permeability-based classification system (PCS) for prediction of ADME/PK in humans. Pharm Res 2008; 25: 625-38.
9. Rinaki E, Valsami G, Macheras P. Quantitative biopharmaceutics classification system: the central role of dose/solubility ratio. Pharm Res 2003; 20: 1917-25.
10. Bastaky J, Lee CY, Goerke J, et al. Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. J Appl Physiol 1995; 79: 1615-28.
11. Steimer A, Haltner E, Lehr CM. Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med 2005; 18: 137.
12. Campbell L, Abulrob AN, Kandalaft LE, et al. Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures. J Pharm Exp Ther 2003; 304: 441-2.
13. Lehmann T, Kohler C, Weidauer E, Taege C, Foth H. Expression of mrp1 and related transporters in human lung cells in culture. Toxicology 2001; 167: 59-72.
14. Tronde A, Norden B, Jeppsson AB et al. Drug absorption from the isolated perfused rat lung - correlations with drug physicochemical properties and epithelial permeability. J Drug Target 2003; 11: 61-74.
15. Derendorf H, Nave R, Drollmann A, Cerasoli F, Wurst W. Relevance of pharmacokinetics and pharmacodynamics of inhaled corticosteroids to asthma. Eur Respir J 2006; 28: 1042-50.
16. Kelly HW. Comparison of inhaled corticosteroids. Ann Pharm 1998; 32: 220-32.
17. Burger H, Foekens JA, Look MP, et al. Rna expression of breast cancer resistance protein, lung resistance-related protein, multidrug resistance-associated proteins 1 and 2, and multidrug resistance gene 1 in breast cancer: Correlation with chemotherapeutic response. Clin Cancer Res 2003; 9: 827-36.
18. Lehmann T, Torky A-R, Stehfest E, Hofmann S, Foth H. Expression of lung resistance-related protein, lrp, and multidrug resistance-related protein, mrp1, in normal human lung cells in longterm cultures. Arch Toxicol 2005; 79: 600-9.
19. Sakagami M. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 2006; 58: 1030-60.
20. Forbes B, Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005; 60: 193-205.
21. Finkbeiner WE. Reverse transcription-polymerase chain reaction (RT-PCR) phenotypic analysis of cell cultures of human tracheal epithelium, tracheobronchial glands, and lung carcinomas. Am J Respir Cel Mol Biol 1993; 9: 547-56.
22. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S. Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin in the tight junctions. J Cell Biol 1994; 127: 1617-26.
23. Wan H, Winton HL, Soeller C, et al. Tight junction properties of the immortalized human bronchial epithelial cell lines Calu-3 and 16HBE14o-. Eur Respir J 2000; 15: 1058-68.
24. O'Shaughnessy C. Calu-3 in the horizontal diffusion chamber system: a model of pulmonary drug transport. Pharm Res 1996; 13: S169.
25. Foster KA, Avery ML, Yazdanian M, Audus KL. Characterization of the calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 2000; 208: 1-11.
26. Haws C, Finkbeiner WE, Widdicombe JH, Wine JJ. Cftr in calu-3 human airway cells: channel properties and role in camp-activated cl- conductance. Am J Physiol 1994; 266: L502-512.
27. Søndergaard H, Brodin B, Nielsen C. Hpept1 is responsible for uptake and transport of gly-sar in the human bronchial airway epithelial cell-line calu-3. Eur J Physiol 2008; 456: 611-22.
28. Elbert KJ, Schäfer UF, Schäfers H-J, Kim K-J, Lee VHL, Lehr CM. Monolayers of human alveolar epithelial cells in primary culture for pulmonary absorption and transport studies. Pharm Res 1999; 16: 601-8.
29. Geys J, Coenegrachts L, Vercammen J, et al. In vitro study of the pulmonary translocation of nanoparticles: a preliminary study. Toxicol Lett 2006; 160: 218-26.
30. Steimer A, Franke H, Haltner-Ukomado E, Laue M, Ehrhardt C, Lehr CM. Monolayers of porcine alveolar epithelial cells in primary culture as an in vitro model for drug absorption studies. Eur J Pharm Biopharm 2007; 66: 372-82.
31. Fuhrmann M, Jahn HU, Seybold J, et al. Identification and function of cyclic nucleotide phosphodiesterase isoenzymes in airway epithelial cells. Am J Respir Cell Mol Biol 1999; 20: 292-302.
32. Ernst N, Ulrichskotter S, Schmalix WA et al. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J Gene Med 1999; 1: 331-40.
33. Boekema BK, Stockhofe-Zurwieden N, Smith HE, Kamp EM, van Putten JP, Verheijden JH. Adherence of actinobacillus pleuropneumoniae to primary cultures of porcine lung epithelial cells. Vet Microbiol 2003; 93: 133-44.